Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...
5don MSN
Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...
U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...
Shortly after Starboard Value pitched four nominees for Kenvue's | Activist investor Starboard Value proposed four additions ...
PARIS] Ozempic-maker Novo Nordisk is planning to make more of its medicines for the US market in the country; Boeing risks a ...
Empire Discovery Institute (EDI), a leading non-profit drug discovery and development accelerator, is pleased to announce the appointment of Dr. Ronald Newbold as Chief Executive Officer (CEO). Dr.
The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback